Stämning: Cannabisföretag anklagas för att ha mörkat risker för psykisk ohälsa | NTD NYHETER

NTD Sverige
111 followers
Cannabisföretag i 13 amerikanska delstater har stämts i en federal grupptalan. De anklagas för att inte ha informerat konsumenterna tillräckligt om de psykiska hälsorisker som kan vara förknippade med cannabisbruk.
NTD:s Daniel Monaghan har intervjuat John Puls, specialist inom beroendemedicin, som menar att rättsprocessen kan leda till krav på varningstexter på cannabisprodukter, begränsningar av THC-halten samt skärpta regelverk för branschen.
#usa #hälsa #cannabis #svenska_undertexter
Se mer: https://ntdtv.se/
AI Generated·May contain errors
Next, a good a big tobacco moment becoming for marijuana.
Cannabis companies in 13 states are facing a federal class action lawsuit
accusing them of misleading consumers about the health risks of their products.
NDD's Daniel Monaghan spoke with an addiction specialist about this case. Have a look at that.
The lawsuit was filed last month by the law firm White's in Luxembourg.
It alleges manufacturers promoted cannabis for benefits such as anxiety and sleep relief
while failing to adequately warn about potential mental health harms including
cannabis-induced psychosis. The complaint cites research linking frequent cannabis use
to a higher risk of schizophrenia and other psychotic disorders.
They highlight really three main things, which is the cannabis-induced psychosis
and the rates of cannabis-induced psychosis, something called cannabinoid hyperemesis syndrome
and then also the other mental health risks associated with it.
Master certified addiction professional John Pulse says research has linked cannabis use
to psychosis in one to three percent of users, adding that there needs to be more transparency
about the risks. If you were to buy a product from the grocery store and even if you really
liked it and for most people it was fine but it carried a one to three percent chance of having
a psychotic break, I think there should be transparency about that. Pulse says the lawsuit
resembles earlier legal battles against tobacco companies which ultimately led to warning labels,
marketing restrictions and tighter regulations. It went from arguably over-policing, over-enforced,
total prohibition to now broad legalization in most states with very little regulations.
And there's really no product, whether you look at tobacco, alcohol or anything else
similar, there's no product that has this little regulation and oversight. You can't, for example,
have flavored cigarettes anymore. That was determined in the courts. But you could have
any type of flavored THC product, THC gummies, cookies, candies, lollipops that are really high
potency. The addiction specialist believes the lawsuits will result in what he views as more
common sense policies including warning labels, regulations around THC content, what type of
products can be sold so that hopefully they can come to a middle ground instead of these two extremes.
Pulse finds it curious that many people report that marijuana relaxes them.
They almost view it as a way to unwind from the day. But if you monitor somebody through some type
of medical monitoring equipment, what you actually see is the vast majority of people, even those who
say that it's relaxing them, experience an increase in heart rate and their blood pressure increases.
Pulse says research shows that the number of emergency room visits related to cannabinoid
hyperemesis syndrome has risen sharply from 4.4 per 100,000 in 2016 to over 22 per 100,000 in 2022.
The symptoms are often referred to as scrommeting when you're scream vomiting at the same time.
And the risk there is dehydration when you can't keep the fluids down. And that's how most people
end up in the emergency room. Supporters of legal cannabis argue millions of Americans use marijuana
without serious adverse effects and say regulated markets are safer than illicit products.
Daniel Monaghan, NTD News.
